Joseph N. Garner, Ph.D. – Chief Executive Officer & Managing Shareholder

Dr. Garner serves as the Chief Executive Officer and Chairman of Endomimetics, LLC.  Endomimetics has developed a BioNanomatrix that can be used to coat these devices and mimic human tissue which minimizes the need for additional surgeries, improves the longevity of the device, reduces complications associated with having foreign items implanted in your body.

Dr. Garner previously served as the Chairman and Chief Executive Officer of Soluble Therapeutics, Inc. in Birmingham, Alabama until it was sold to Cytocentrics, Inc. on November 1st of 2016. Soluble Therapeutics is commercializing the HSCTM Technology, licensed from the UAB Research Foundation, to speed the research, development, and government approval of protein-based therapeutics, diagnostics, and vaccines.

Read More

Dr. Garner received the Entrepreneur Spotlight award given by the Birmingham Business Journal in 2014. He has served on the UAB School of Health Professions Honors and Recognition Committee, as the Chairman of both the Business Development Advisory Council (BDAC) and the Armed Forces Communications and Electronics Association (AFCEA) in Frederick County Maryland. He has also been a member of the Tech Council of Maryland (TCM), Steering Committee for the Frederick Network of TCM, the American Society of Microbiology (ASM), and has been a member of the American Society for Pharmacology and Experimental Therapeutics (ASPET). Dr. Garner has presented his research worldwide at scientific meetings such as “Translation UK” in Dundee, Scotland and “International Marine Biotechnology Conference” in Australia.

In addition to Dr. Garner’s commercial efforts, he is a part-time Assistant Professor in the UAB Biotechnology Program. The biotechnology program at UAB provides students with the training necessary to be a part of the industry’s specialized workforce with a strong knowledge base in science, technology and research and industry-specific entrepreneurial skills that can translate scientific discovery into commercial products.

Previous to Soluble Therapeutics, Dr. Garner was the President and Chief Operating Office of BridgePath Scientific (BPS). BPS services the international scientific community through the provision of scientific equipment, disposables, research reagents and kits, and contract research services.

Prior to BridgePath Scientific, Dr. Garner was the Founder, and CEO of Advanced Product Enterprises, LLC.  Dr. Garner served as a Senior Investigator and the Director of Marketing and Sales for Biological Mimetics, Inc. a Frederick Maryland based, vaccine development company.